Forgot Login/Password?
Complete Story
 

Learning Objectives OPA Home Study Educational Programming: Patient Safety, Law & Immunization

Objectives for OPF Home-Study Continuing Education

Patient/Medication Safety Home-Study CPE

Recognizing and Preventing Vaccine Errors
ACPE Program #0129-0000-17-006-H05-P
Objectives. At the completion of this activity, the participant will be able to:

  1. demonstrate an understanding of the process to submit errors to the Institute for Safe Medication Practices (ISMP) National Vaccine Errors Reporting Program (VERP);
  2. list types of vaccine errors reported and commonly associated with vaccines;
  3. recognize strategies to minimize vaccine-related errors;
  4. identify workplace policy and procedures and strategies that can help minimize the risk of errors; and
  5. list missed opportunities related to potential vaccine-related errors.

A New Generation of Medical Errors with the Rise of Health Information Technology
ACPE #0129-0000-16-007-H05-P
Objectives. At the completion of this activity, the participant will be able to:

  1. demonstrate an understanding of the rationale for the continued development and implementation of electronic prescribing in community pharmacies and across other health systems;
  2. list advantages of utilization of electronic prescribing in community pharmacies;
  3. identify drawbacks, common sources of errors, and workflow issues related to electronic prescribing; and
  4. recognize solutions for identifying and resolving medication-related errors associated with electronic prescribing and for reducing alert fatigue.

Law Home-Study CPE

Pharmacy Technician Updates to Ohio Pharmacy Laws and Rules
ACPE #0129-0000-18-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

  1. list the requirements for and permitted functions of registered pharmacy technicians, certified pharmacy technicians, and pharmacy technician trainees in the state of Ohio;
  2. identify educational programs approved for training registered and certified pharmacy technicians;
  3. differentiate didactic and experiential training required of employer-based pharmacy training programs;
  4. recognize continuing education requirements of registered and certified pharmacy technicians; and
  5. demonstrate an understanding of the disciplinary authority granted to the Board of Pharmacy.

Important Updates to Ohio Pharmacy Laws and Rules
ACPE #0129-0000-17-102-H03-P
Objectives. At the completion of this activity, the participant will be able to:

  1. recognize the new requirements for prescribers to treat acute pain with opioids and the pharmacist’s corresponding responsibility;
  2. list the requirements for a pharmacy technician to qualify as a registered pharmacy technician or a certified pharmacy technician by the State of Ohio Board of Pharmacy under Ohio Revised Code; and
  3. demonstrate an understanding of the authorization process, protocol requirements, and procedures for a pharmacist to administer dangerous drugs to patients by injection.

Legal Requirements for Buprenorphine for Opioid Addiction
ACPE #0129-0000-17-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

  1. recognize the rise of opioid overdose deaths particularly from the upsurge of heroin usage;
  2. identify steps taken to decrease the supply of prescription opioids to treat pain in Ohio;
  3. exhibit knowledge of the evolution of medication-assisted treatment (MAT) programs;
  4. outline the legal requirements for Office Based Opioid Treatment utilizing buprenorphine-containing products; and
  5. demonstrate an understanding of the scope and methods of diversion of buprenorphine-containing products and steps the pharmacist can take to combat them.

Pharmacy Law: Legislative and Regulatory Update 2015-2016
ACPE #0129-0000-16-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

  1. identify recent changes in pharmacy law and rule to expand pharmacy practice in the areas of physician consult agreements, naloxone dispensing, and pharmacist-administered immunizations;
  2. demonstrate an understanding of dispensing changes in the criteria for mandatory obtaining of OARRS reports, compounding, emergency medication supplies, and expedited partner therapy; and
  3. list the new requirements for pharmacist license renewal.

Immunization Home-Study Offerings

Immunizations for HPV, Varicella, Hib, and Polio
ACPE #0129-0000-18-053-H06-P
Objectives.  At the completion of this activity, the participant will be able to:

  1. identify the diseases caused by human papillomavirus (HPV), varicella, Haemophilus influenzae type b (Hib) and polio; and state the epidemiology of these vaccine-preventable diseases;
  2. list the recommendations for immunization of persons seven years of age or older for these vaccines, including appropriate patient populations, doses, route of administration, and injection sites;
  3. recognize the precautions, contraindications, and adverse reactions associated with these vaccines, as well as monitoring and treatment of patients with adverse reactions; and
  4. list the storage and handling requirements of HPV, varicella, Hib, and polio vaccines.

Immunizations for Selected Vaccine-Preventable Diseases
ACPE# 0129-0000-17-014-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. exhibit knowledge of the immune system, types of antigens, and types of immunity;
  2. identify effective immunization strategies for prevention of influenza, pneumonia, hepatitis A & B, meningitis, tetanus, diphtheria, pertussis, herpes zoster, measles, mumps, and rubella in at-risk populations, and the roles of health care providers;
  3. demonstrate an understanding of the currently available vaccines for the diseases discussed, including indications, dosing recommendations, contraindications and precautions, adverse reactions, and storage requirements;
  4. outline appropriate monitoring and treatment of the vaccine for adverse reactions including the use of epinephrine and diphenhydramine;
  5. recognize how to report vaccine adverse events; and
  6. list key sources for current information on vaccines.

Immunizations for Typhoid, Yellow Fever, Japanese Encephalitis, Cholera and Rabies
ACPE #0129-0000-16-120-H01-P
Objectives
At the completion of this activity, the participant will be able to:

  1. identify persons who should be vaccinated with typhoid, yellow fever, Japanese encephalitis, cholera and rabies vaccines;
  2. recognize the epidemiology and signs and symptoms of each disease; and
  3. list dosage, route of administration, adverse reactions, contraindications and storage requirements for each vaccine.

Long-Acting Injectables Home-Study Offerings

Injectable Cobalamin Review for Pharmacists
ACPE #0129-0000-18-066-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. identify the mechanism of action of cobalamin and etiology of cobalamin deficiency;
  2. demonstrate an understanding of appropriate treatment of cobalamin deficiency, including affected patient populations, dosages, administration schedules, routes of administration, and storage;
  3. list adverse reactions, precautions, and contraindications of cobalamin injections, as well as monitoring and treatment of patients who experience an allergic reaction; and
  4. recognize patient concerns that may arise, including patient privacy and storage of patient's prescriptions in the pharmacy.

Injectable Medroxyprogesterone Acetate Review for Pharmacists
ACPE #0129-0000-18-067-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. recognize the therapeutic role of medroxyprogesterone acetate in contraception;
  2. identify pharmacokinetic and pharmacodynamic properties of medroxyprogesterone acetate;
  3. list precautions, contraindications, and adverse reactions of medroxyprogesterone acetate; and recognize appropriate treatment for severe allergic reactions; and
  4. demonstrate an understanding of the appropriate dosing and administration of medroxyprogesterone acetate.

Injectable Hydroxyprogesterone Caproate Review for Pharmacists
ACPE #0129-0000-18-068-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. identify patients who are indicated to receive hydroxyprogesterone caproate injection;
  2. identify contraindications to hydroxyprogesterone caproate therapy;
  3. demonstrate an understanding of proper storage and administration of hydroxyprogesterone caproate injection; and
  4. recognize common adverse reactions associated with hydroxyprogesterone injections and how to manage them.

Long-Acting Injectable Antipsychotics Review for Pharmacists
ACPE #0129-0000-18-069-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. recognize the therapeutic role of long-acting injectable antipsychotics and demonstrate an understanding of the disorders they are used to treat;
  2. demonstrate an understanding of mechanisms of action and appropriate dosing and administration of long-acting injectable antipsychotics;
  3. list precautions, contraindications, and adverse reactions of long-acting injectable antipsychotics; and recognize appropriate treatment for severe allergic reactions; and
  4. recognize the importance of acute and chronic monitoring for these medications.

Injectable Naltrexone Review for Pharmacists
ACPE #0129-0000-18-070-H01-P
Objectives. At the completion of this activity, the participant will be able to:

  1. recognize the therapeutic role of naltrexone in, and evidence for, treatment of alcohol use and opioid use disorders;
  2. identify the mechanisms of action and appropriate dosing and administration of extended-release injectable naltrexone;
  3. list precautions, contraindications, and adverse reactions of extended-release injectable naltrexone; and recognize appropriate treatment for adverse reactions; and
  4. demonstrate an understanding of the monitoring, special populations and storage of extended-release injectable naltrexone.

Printer-Friendly Version


Get OPA Events via RSS

Events

 July 2019 
SMTWTFS
 123456
789101112
13
141516
171819
20
21
222324252627
282930
31   
August 20, 2019
11:00AM

Live Webinar: Required OSHA Training for Immunizing Pharmacists

August 21, 2019
7:30AM-5:15PM

APhA's Delivering MTM Services Certificate Training Program for Pharmacists

OPA Office- 2674 Federated Blvd, Columbus, OH 43235

August 27, 2019
7:30AM-5:15PM

APhA's Diabetes Care Certificate Training Program for Pharmacists

OPA Office, 2674 Federated Blvd, Columbus, OH 43235

September 8, 2019

OPA Compound Conference

Embassy Suites by Hilton in Dublin, Ohio

September 19, 2019
11:00AM

Live Webinar: Required OSHA Training for Immunizing Pharmacists